Viewing StudyNCT00182806



Ignite Creation Date: 2024-05-05 @ 11:56 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00182806
Status: COMPLETED
Last Update Posted: 2012-03-06
First Post: 2005-09-15

Brief Title: Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor: Roswell Park Cancer Institute
Organization: Roswell Park Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Lung Cancer
Keywords:
Name View
stage IV non-small cell lung cancer View
recurrent non-small cell lung cancer View
stage IIIA non-small cell lung cancer View
stage IIIB non-small cell lung cancer View